Claims for Patent: 5,460,978

Summary for Patent: 5,460,978

Title:	Protein active in humoral hypercalcemia of malignancy-PthrP
Abstract:	Substantially pure parathyroid hormone related protein (PTHrP) active in humoral hypercalcemia of malignancy and sub-units and fragments thereof. Antibody reagents capable of binding to epitopes of PTHrP. Methods and kits for the detection of PTHrP.
Inventor(s):	Martin; Thomas J. (Kew, AU), Moseley; Jane M. (North Balwyn, AU), Kemp; Bruce E. (Kew, AU), Wettenhall; Richard E. H. (Camberwell, AU)
Assignee:	The University of Melbourne (Parkville, AU)
Application Number:	07/715,280
Patent Claims:	1. A method for the detection of parathyroid hormone related protein or fragments thereof in a given protein containing sample, comprising contacting the sample, or a support matrix onto which protein in the sample is immobilized, with antibody reagents that bind to epitopes of parathyroid hormone related protein and that bind to epitopes of said fragments, and subsequently detecting the presence or absence of antibody binding; wherein said parathyroid hormone related protein to be detected has the following characteristics: (a) an N-terminal amino acid sequence A V S E H Q L L H D K G K S I Q D L R R R F F L H H L I A E I H T A E I R A T S E --S--N; and (b) a molecular weight between 15 to 25 kilodaltons, as determined by sodium dodecyl polyacrylamide gel electrophoresis under reducing and non-reducing conditions. 2. A method as claimed in claim 1 wherein the antibodies that bind epitopes of parathyroid hormone related protein are labelled with a detectable marker. 3. A method as claimed in claim 1, wherein the presence or absence of antibody binding to parathyroid hormone related protein, is detected by reagents labelled with a detectable marker that binds to antibodies. 4. A method for the detection of parathyroid hormone related protein or fragments thereof in a given sample, comprising incubating the sample with a support matrix, onto which antibodies that bind epitopes of parathyroid hormone related protein are bound, for a time sufficient to allow antibody binding, and thereafter detecting the presence or absence of bound parathyroid hormone related protein with antibody reagents that bind to epitopes of parathyroid hormone related protein and that bind to epitopes of said fragments; wherein said parathyroid hormone related protein to be detected has the following characteristics: (a) an N-terminal amino acid sequence A V S E H Q L L H D K G K S I Q D L R R R F F L H H L I A E I H T A E I R A T S E --S--N; and (b) a molecular weight between 15 to 25 kilodaltons, as determined by sodium dodecyl polyacrylamide gel electrophoresis under reducing and non-reducing conditions. 5. A method as claimed in claim 4, wherein the antibody reagents used to detect the presence or absence of parathyroid hormone related protein in a given sample are labelled with a detectable marker. 6. A method as claimed in claim 4, wherein the binding or absence of binding of antibody reagents to parathyroid hormone related protein is detected with reagents labelled with a detectable marker.

Details for Patent 5,460,978

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2012-10-24